Induction of immune response in chickens primed in ovo with an inactivated H9N2 avian influenza virus vaccine
- PMID: 29970157
- PMCID: PMC6029274
- DOI: 10.1186/s13104-018-3537-9
Induction of immune response in chickens primed in ovo with an inactivated H9N2 avian influenza virus vaccine
Abstract
Objective: Infection of chickens with low pathogenic avian influenza virus, such as H9N2 virus, culminates in decreased egg production and increased mortality and morbidity if co-infection with other respiratory pathogens occurs. We have previously observed the induction of antibody- and cell-mediated immune responses after intramuscular administration of an H9N2 beta-propiolactone inactivated virus vaccine to chickens. Given the fact that in ovo vaccination represents a practical option for vaccination against H9N2 AIV in chickens, in the current study, we set out to characterize immune responses in chickens against a beta-propiolactone inactivated H9N2 virus vaccine after primary vaccination in ovo on embryonic day 18, and secondary intramuscular vaccination on day 14 post-hatch. We also included the Toll-like receptor 21 ligand, CpG ODN 2007, and an oil emulsion adjuvant, AddaVax™, as adjuvants for the vaccines.
Results: Antibody-mediated immune responses were observed after administering the secondary intramuscular vaccine. Cell-mediated immune responses were observed in chickens that received the beta-propiolactone inactivated H9N2 virus combined with AddaVax™. Our results demonstrate that adaptive immune responses can be induced in chickens after a primary in ovo vaccination and secondary intramuscular vaccination.
Keywords: Antibody; Beta-propiolactone; Cell-mediated; CpG ODN; H9N2 avian influenza virus; In ovo; Intramuscular; Toll-like receptor 21; Vaccine.
Figures



Similar articles
-
A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.Viral Immunol. 2018 Nov;31(9):605-612. doi: 10.1089/vim.2018.0072. Epub 2018 Sep 15. Viral Immunol. 2018. PMID: 30222508
-
Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.Vaccine. 2018 Jun 22;36(27):3908-3916. doi: 10.1016/j.vaccine.2018.05.093. Epub 2018 May 28. Vaccine. 2018. PMID: 29853199
-
Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.Vaccine. 2015 Jul 31;33(32):3947-52. doi: 10.1016/j.vaccine.2015.06.043. Epub 2015 Jun 16. Vaccine. 2015. PMID: 26092309
-
Strategies for enhancing immunity against avian influenza virus in chickens: a review.Avian Pathol. 2022 Jun;51(3):211-235. doi: 10.1080/03079457.2022.2054309. Epub 2022 May 5. Avian Pathol. 2022. PMID: 35297706 Review.
-
Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China.Life (Basel). 2022 Aug 27;12(9):1326. doi: 10.3390/life12091326. Life (Basel). 2022. PMID: 36143363 Free PMC article. Review.
Cited by
-
Development and function of chicken XCR1+ conventional dendritic cells.Front Immunol. 2023 Oct 25;14:1273661. doi: 10.3389/fimmu.2023.1273661. eCollection 2023. Front Immunol. 2023. PMID: 37954617 Free PMC article.
-
Vaccines against Major Poultry Viral Diseases: Strategies to Improve the Breadth and Protective Efficacy.Viruses. 2022 May 31;14(6):1195. doi: 10.3390/v14061195. Viruses. 2022. PMID: 35746665 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical